Abstract
As part of an effort to identify substrate analogs suitable for helping to resolve structural features important for terpene synthases, the inhibition of 5-epi-aristolochene biosynthesis from farnesyl diphosphate (FPP) by the tobacco 5-epi-aristolochene synthase incubated with anilinogeranyl diphosphate (AGPP) was examined. The apparent noncompetitive nature of the inhibition supported further assessment of how AGPP might be bound to crystallographic forms of the enzyme. Surprisingly, the bound form of the inhibitor appeared to have undergone a cyclization event consistent with the native mechanism associated with FPP catalysis. Biocatalytic formation of a novel 13-membered macrocyclic paracyclophane alkaloid was confirmed by high-resolution GC-MS and NMR analysis. This work provides insights into new biosynthetic means for generating novel, functionally diversified, medium-sized terpene alkaloids. (Figure Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 1729-1736 |
| Number of pages | 8 |
| Journal | ACS Chemical Biology |
| Volume | 10 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 17 2015 |
Bibliographical note
Publisher Copyright:© 2015 American Chemical Society.
Funding
| Funders | Funder number |
|---|---|
| Howard Hughes Medical Institute | |
| National Institutes of Health (NIH) | GM054029, GM66152, 1RC2GM092521 |
| National Science Foundation Arctic Social Science Program | CHE-9974810 |
| National Childhood Cancer Registry – National Cancer Institute | T32CA009370 |
| National Childhood Cancer Registry – National Cancer Institute |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine